234 Users Online
Body Contouring Devices Market Segmented by Non-invasive and Minimally Invasive Devices and Invasive Devices Type in North America, Europe and APAC Regions
The global body contouring devices market was valued at US$ 1,190 Million in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 15% from 2022 to 2032. Body contouring devices can be invasive and non-invasive or minimally invasive, which aim to reshape an area of the body. This can be done surgically via liposuction or through less invasive methods like cryo lipolysis, injection lipolysis, radiofrequency lipolysis, and laser lipolysis. The main goal of body contouring procedures is to eliminate unwanted and achieve firmness in the treatment area.
Body Contouring Devices Market Size (2022)
US$ 1,368.50 Million
Projected Market Value (2032F)
US$ 5,536.35 Million
Global Market Growth Rate (2022-2032)
In 2021, Non-invasive and Minimally Invasive Devices held a maximum share of 77.0%. Entry of various products, investment by market players, and high demand for non-invasive and minimally invasive procedures due to their safe and cost-effective nature have been driving the market.
Invasive body contouring procedure, Liposuction or lipolysis, has remained one of the most popular and in-demand plastic surgery procedures for body contouring and is particularly effective in removing fat in the legs, abdomen, back, arms, face, and neck. According to the American Society of Plastic Surgeons (ASPS), liposuction was the second-most carried out procedure in the U.S. after breast augmentation, with 211,067 procedural volumes in 2020.
Liposuction is considered one of the most effective procedures for body fat removal, as it can remove up to 5 liters (11 pounds) of fat from this procedure. However, with the advent of non-invasive treatments that are cost-effective and deliver the same results, the demand for liposuction has witnessed a slight decline. According to Healthline, as the procedure requires surgical intervention, its cost might be more than other procedures and this might impede the market growth. Owing to these factors, the demand for body contouring devices is projected to be on a rise through 2032.
Rising Cases of Obesity across the globe anticipated to drive the Global Market
Rising cases of obesity across the globe due to unhealthy lifestyles are anticipated to drive the global market. Improved safety and efficacy of these techniques resulting in increased life expectancy are also expected to boost their demand. Initiatives, such as M&A, novel product launches, and partnerships, undertaken by major companies for product research and distribution are expected to drive the market further in the coming years.
Non-invasive fat reduction or nonsurgical fat reduction includes minimally invasive treatments that break down stubborn subcutaneous fat pockets beneath the skin. Major factors driving market growth include rising demand for body contouring treatment, as it is non-invasive and requires no downtime after completion of the procedure. SculpSure, developed by Cynosure, Inc., is a non-invasive body contouring laser device that targets and destroys around 24% of unwanted fat cells in 25 minutes.
According to WHO, obesity is a global epidemic that has tripled since 1975, and currently, about 30% of the world’s population is obese. A sedentary lifestyle is a major underlying cause of obesity, disease, and disability. Levels of physical inactivity are virtually high in all developed and developing countries. Increased urbanization has contributed immensely to the increase in sedentary lifestyles which in turn escalated the prevalence of obesity globally.
All aesthetic procedures were significantly affected amid the pandemic, restraining the market growth
The advent of the COVID-19 pandemic affected the overall aesthetic market. But many aesthetic professionals believe that the pandemic might most likely propel the body contouring market. According to the American Society of Plastic Surgeons, the pandemic led to an increase in the acceptance of cosmetic procedures and many women are now more inclined and interested in nonsurgical procedures than before the pandemic.
The advent of the COVID-19 pandemic had affected the overall aesthetic and beauty market. All invasive and non-invasive aesthetic procedures were significantly affected amid the pandemic; this includes the body contouring market. According to Bloomberg, procedures such as non-invasive fat reduction, injection lipolysis, invasive liposuction soft tissue fillers, facelifts, eye lifts, eyelid surgeries, laser skin resurfacing, rhinoplasty, and tummy tucks decreased by 20% in the first half of 2020.
However, The International Society of Aesthetic Plastic Surgery reported that the willingness and demand for cosmetic treatments like body contouring increased drastically by the end of 2020 and reached higher than the pre-pandemic levels in 2021.
Rising Development of Healthcare Infrastructure Driving Sales of Body Contouring Devices
North America dominated the body contouring devices market with a share of 35.6% in 2021 and is expected to showcase a significant CAGR in the forecast period. This is attributed to the rising geriatric population, strong medical infrastructure, well-established reimbursement policies, the existence of key market players, and advancements in aesthetic body contouring procedures. Moreover, attributes like high acceptance and openness towards body contouring treatments, and soaring appearance-conscious customer pool is likely to propel the non-invasive body contouring market in the region of North America.
APAC region is expected to witness the highest CAGR of 15.2% over the forecast period. Asian countries such as China, Japan, and India are emerging economies with well-developed healthcare infrastructure and facilities and are now more focused on leading based on R&D activities. Asian countries have been a long renowned hub for aesthetic procedures.
Why are Suppliers of Body Contouring Devices Investing in the U.S.?
Supportive Government Initiatives & High Spending on Healthcare R&D
The United States is known for its developed healthcare infrastructure and extensive research activity, which makes it a favorable market for body contouring devices. The presence of modern healthcare infrastructure and the presence of leading market players also make the U.S. a highly rewarding market for body contouring devices suppliers and manufacturers. Increasing support from the government of the U.S. is another factor that will uplift body contouring devices market potential over the coming years.
A large number of obesity cases in the United States of America is expected to propel market growth over the forecast period. As per the article on Overweight and Obesity by the United States Centers for Disease Prevention and Control updated in May 2022, the National Health Statistics Reports 2021 indicated that the obesity prevalence had increased to 41.9% in 2020 from 30.5% in the year 2000. The article also stated that around 14.7 million children and adolescents were affected by obesity in the nation. This is likely to positively impact the market growth in the region.
How Will the China Body Contouring Devices Market Evolve?
Rising Awareness of Chronic Diseases & Growing Senescent Population
Focus on healthcare in China is increasing and this trend was particularly boosted by the outbreak of coronavirus in 2020, which is expected to primarily drive body contouring devices market potential in the country through 2032. Awareness of obesity related diseases, increasing healthcare expenditure, and favorable government policies to boost healthcare infrastructure development are other factors that positively impact body contouring devices market growth in China. Furthermore, numerous fat reduction procedures, cost-effective and high-quality treatments, rising disposable income, and growing obese & geriatric population are driving the market in the region.
Which Application Accounts for Highest Demand for Body Contouring Devices?
Non-Surgical Skin Tightening Segment to account for a Higher Market Share
The non-surgical skin tightening application segment held a significant market share of 21.1% in 2021. Based on the body contouring procedure the market has been segmented into nonsurgical skin resurfacing, non-surgical skin tightening, cellulite treatment, liposuction, and others. In 2021, the Non-surgical skin tightening segment accounted for a high market share and is expected to grow at a fast rate during the forecast period. This can be attributed to the minimally invasive and non-invasiveness of the procedures and low cost as compared to an invasive procedure.
The other segment includes injectable body contouring and gastric band. Injectable body contouring can be done by FDA-approved treatment injections called Kybella. This injection contains deoxycholic acid, which is naturally produced by the body to target fat cells. Kybella is injected every month for 3 to 6 sessions and after the treatment, the body breaks down & absorbs fat cells.
Non-Surgical Skin Tightening is also expected to show significant market growth of 15.0% during the forecast period. This is because, with age, collagen increases, and elastin production in the body decreases, giving the appearance of fine lines and dull & sagging skin. Non-invasive tightening devices like Thermage, Ulthera, and Pelleve assist in stimulating collagen and elastin production by inducing laser or ultrasound energy in the target area, which gradually improves the skin's texture & tone.
Top companies in the body contouring devices market are focusing on advancing their research and fast-tracking the development of new body contouring devices to launch new products and gain a competitive advantage over other market players.
Major players are channeling efforts toward expanding their production capacities to strengthen their market share and cater to the growing demand for fatty amides. Market expansion is anticipated to be aided by the growing number of partnerships and collaborations among key players that are looking to increase their presence in the market.
By Application type
The global body contouring devices market accounts for a revenue of US$ 1368.50 million in 2022.
The global market for body contouring devices is expected to reach US$ 5536.35 billion by 2032.
Demand for body contouring devices from 2022 to 2032 is projected to expand at a stellar CAGR of 15%.
By 2032, Non-invasive and Minimally Invasive Devices are projected to hold a maximum share of 77.0% of the market.
Key suppliers of body contouring devices are Cynosure, Inc.; Alma Lasers; Merz Pharma Gmbh; Allergan; Syneron Medical Ltd.; Bausch Health Companies, Inc.; Lutronic Corporation; InMode Ltd; Fotona; Sofwave Medical LTD, Sciton Inc and Lumenis.